Macoin, J., R. Lissilaa, P. Sancheti, V. Reddy, J. Back, and G. Wolff. “Targeting OX40 With GBR 830, An OX40 Antagonist, Inhibits T Cell-Mediated Pathological Responses”. SKIN The Journal of Cutaneous Medicine, vol. 2, Dec. 2018, p. S62, doi:10.25251/skin.2.62.